TrialBritish journal of cancer2010

Randomised, non-comparative phase II study of weekly docetaxel with cisplatin and 5-fluorouracil or with capecitabine in oesophagogastric cancer: the AGITG ATTAX trial.

N C Tebbutt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.